AUGMENTIN TABLETS

GSK

Revision date : 2025-04-14

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

9004-34-6

Name of the chemical

cellulose

Concentration

5.12

EC/CAS

7631-86-9

Name of the chemical

Silver adsorbed on silicon dioxide

Concentration

8-<34

General Information

Revision date

2025-04-14

Product name

AUGMENTIN TABLETS

Product Synonyms

AUGMENTIN 156.25 MG TABLETS *AUGMENTIN 250 MG TABLETS * AUGMENTIN 500 MG TABLETS * AUGMENTIN 187.5 MG TABLETS * AUGMENTIN 375 MG TABLETS *AUGMENTIN 625 MG TABLETS * AUGMENTAN TABLETS *AUGMENTIN 2 1 TABLETS * AUGMENTIN 4 1 TABLETS * CLAVULIN 250 TABLETS * CLAVULIN 500F TABLETS * AMOCLAV 375 MG TABLETS * AMOCLAYV 625 MG TABLETS * CLAMOXYL TABLETS 250 MG * SPEKTRAMOX 375 MG FINAL TABLETS * AMOXICILLIN TRIHYDRATE AND POTASSIUM CLAVULANATE, FORMULATED PRODUCT

Emergency telephone

+1-888-825-5249, +1-877-844-8872, +(1) 760 476 3971, +(1) 760 476 3962, +(1) 866 519 4752

Icons in SDS

GHS08 M004 M009 M010 M011 M017

Company Information

company name

GSK

e-mail address of the competent person responsible for the Safety Data Sheet

msds@gsk.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H317, H334

Hazard statements

Code

Statements

H317

May cause an allergic skin reaction

Section 2

SECTION 2: Hazards identification

OSHA defined hazards ‘Hazards for the product as sold

Physical hazards

Not classified

Health hazards

Sensitization, respiratory Category 1 Sensitization, skin Category 1

Environmental hazards

Not classified

Signal word

Danger

Hazard statements

May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled.

Prevention

Avoid breathing dust. Contaminated work clothing must not be allowed out of the workplace. Wear protective gloves. In case of inadequate ventilation wear respiratory protection.

Response

If on skin Wash with plenty of water/. Wash contaminated clothing before reuse. If inhaled If breathing is difficult, remove person to fresh air and keep comfortable for breathing. If skin irritation or rash occurs Get medical advice/attention. Specific treatment (see instruction on this label). If experiencing respiratory symptoms Call a poison center/doctor.

Storage

Not available.

Disposal

Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health classified (HNOC) hazards

Additional information

93.12% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 93.12% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. Contains AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE. May produce an allergic reaction.

2.1 Classification of the substance or mixture

Not classified. Health hazards Sensitization, respiratory Category 1 Sensitization, skin Category 1 Environmental hazards Not classified. OSHA defined hazards Not classified. Material name: AUGMENTIN TABLETS SDS US 2928 \Version # 23 Revision date: 04-14-2025 Issue date: 05-25-2018 1/12

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.